main content start
Oncology 19m 43s

Importance of equitable access to cancer Medicine : A Viewpoint

Published 20 Jul 2022
Although we have seen major drop-in death rates & improved 5 years survival for patients with cancer, 5-year survival rates for cancer patients are lower in Lower- and Middle-Income Countries (LMICs) compared to USA & Europe. Newer drugs like Immunotherapy & Targeted therapies are effective from the clinical standpoint but do not turn out to be cost effective every time. Access to companion diagnostics is also similar challenge. LMICs also spend less on cancer control and care. An initiative like UN declaration on NCDs is aiming to achieve at access to 80% essential cancer medicines by 2025. Quality generics & Biosimilars, Price discrimination like Tiered Pricing can improve the access to cancer drugs. Universal coverage would be the most important alternative to improve the access to cancer medications.
biosimilars quality generics access

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Perks of registering with us
Access to Online/Offline Events
Personalized Content
Access to all Features
Hi, can I help?
Chat SupportX
Support Team
Hello, how can I help you today?
Please select one of the below options.

Find Information

Unable to Login or Register

Want to share feedback